Product Information
MUCUS RELIEF D ER 600-60 MG TB is a generic product labeled by Cardinal Health, priced at $0.3841 per EA under NDC 70000072002. Its NADAC has been published 36 times since Jan 28, 2026.
FDA first approved this application on Feb 1, 2022.
Strength
600; 60 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000072002
Classification
Generic
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214407FDA Approved
2/1/2022
On Market Since
3/10/2025
Pharmacological Classes
Price Statistics
The NADAC for MUCUS RELIEF D ER 600-60 MG TB has been published 36 times since Jan 28, 2026, and over the history we have for it it has risen 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3841 per EA |
|---|---|
| All-time high | $0.3891 (Aug 12, 2026) |
| All-time low | $0.3126 (Jan 28, 2026) |
| 52-week high | $0.3891 |
| 52-week low | $0.3126 |
| Median price | $0.3649 |
| Average price | $0.3559 |
| Largest weekly change | +7.3% (May 20, 2026) |
| Weeks tracked | 36 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
guaifenesin and pseudoephedrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCUS RELIEF D ER 600-60 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for MUCUS RELIEF D ER 600-60 MG TB, manufactured by Cardinal Health, is $0.3841 per EA (NDC 70000072002), effective Sep 30, 2026.
How has the price of MUCUS RELIEF D ER 600-60 MG TB changed over time?
Over the history we have for it, the NADAC for MUCUS RELIEF D ER 600-60 MG TB has risen 22.9%. It has been tracked across 36 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for MUCUS RELIEF D ER 600-60 MG TB?
Since Jan 28, 2026, the NADAC for MUCUS RELIEF D ER 600-60 MG TB has ranged from a low of $0.3126 (Jan 28, 2026) to a high of $0.3891 (Aug 12, 2026), with a median of $0.3649 per EA.
Are there cheaper alternatives to MUCUS RELIEF D ER 600-60 MG TB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MUCUS RELIEF D ER 600-60 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures MUCUS RELIEF D ER 600-60 MG TB?
MUCUS RELIEF D ER 600-60 MG TB (NDC 70000072002) is labeled by Cardinal Health, and CMS classifies it as a generic product.